← back to search

Matthew R. Weir

Detroit R&D (United States) · US
Area of research
Transplantation · Nephrology
Research interest
Research interests include Renal Transplantation Outcomes and Treatments, Chronic Kidney Disease and Diabetes, Potassium and Related Disorders, and Organ Transplantation Techniques and Outcomes.
h-index
85
citations
25,291
works
568
NIH funding
primary concept
Medicine
email

Recent publications

Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension
New England Journal of Medicine 2025cited by 89position: middledoi
Differential Effect of Hospitalization on Cystatin C– and Creatinine-Based Estimated GFR
Journal of the American Society of Nephrology 2025cited by 4position: middledoi
A cross-sectional study of the role of epithelial cell injury in kidney transplant outcomes
JCI Insight 2025cited by 4position: middledoi
Postdischarge Care of Acute Kidney Injury Survivors: An Opportunity for Targeted Nurse and Pharmacist Interventions
Advances in Kidney Disease and Health 2025cited by 2position: middledoi
Subthreshold rejection activity in many kidney transplants currently classified as having no rejection
American Journal of Transplantation 2024cited by 26position: middledoi
Incident heart failure in chronic kidney disease: proteomics informs biology and risk stratification
European Heart Journal 2024cited by 19position: middledoi
Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International 2023cited by 131position: middledoi
Albuminuria and Heart Failure
Journal of the American College of Cardiology 2023cited by 106position: middledoi
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases
Journal of Diabetes and its Complications 2023cited by 93position: middledoi
Proteomics of CKD progression in the chronic renal insufficiency cohort
Nature Communications 2023cited by 54position: middledoi
Probing the Association between Acute Kidney Injury and Cardiovascular Outcomes
Clinical Journal of the American Society of Nephrology 2023cited by 9position: middledoi
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial
European Heart Journal 2022cited by 211position: middledoi
Initial Drops in Glomerular Filtration Rate with Certain Drug Classes Retard Kidney Disease Progression
American Journal of Nephrology 2022cited by 17position: lastdoi
Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria
Journal of the American College of Cardiology 2022cited by 12position: middledoi
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases
Journal of Diabetes and its Complications 2021cited by 62position: lastdoi
Patiromer for the management of hyperkalaemia in patients receiving renin–angiotensin–aldosterone system inhibitors for heart failure: design and rationale of the <scp>DIAMOND</scp> trial
European Journal of Heart Failure 2021cited by 44position: middledoi
The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International 2020cited by 562position: middledoi
Characterization and implications of the initial estimated glomerular filtration rate ‘dip’ upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial
Kidney International 2020cited by 208position: middledoi
Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study
American Journal of Kidney Diseases 2020cited by 177position: middledoi
Clinical Management of Hyperkalemia
Mayo Clinic Proceedings 2020cited by 172position: lastdoi
Abnormalities of Potassium in Heart Failure
Journal of the American College of Cardiology 2020cited by 171position: middledoi
Risk Factors for CKD Progression
Clinical Journal of the American Society of Nephrology 2020cited by 156position: middledoi
High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury
American Journal of Transplantation 2020cited by 143position: middledoi
Systematic integrated analysis of genetic and epigenetic variation in diabetic kidney disease
Proceedings of the National Academy of Sciences 2020cited by 108position: middledoi
Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study
American Journal of Kidney Diseases 2020cited by 54position: middledoi
Protein carbamylation and chronic kidney disease progression in the Chronic Renal Insufficiency Cohort Study
Nephrology Dialysis Transplantation 2020cited by 37position: middledoi
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International 2019cited by 470position: middledoi
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and Rationale
Kidney International Reports 2019cited by 103position: middledoi
Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD
American Journal of Kidney Diseases 2019cited by 74position: middledoi
Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease
Hypertension 2019cited by 40position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

George L. Bakris · University of Mississippi15 papers (2014–2023)Jiang He · Medical Research Council13 papers (2014–2025)James P. Lash · University of Illinois Chicago12 papers (2012–2023)Harold I. Feldman · University of Pennsylvania12 papers (2012–2023)Chi‐yuan Hsu · Kaiser Permanente10 papers (2012–2025)Alan S. Go · Kaiser Permanente10 papers (2014–2025)Raymond R. Townsend · Newcastle University9 papers (2012–2020)Jing Chen · Tulane University9 papers (2012–2025)John W. Kusek · National Institute of Diabetes and Digestive and Kidney Diseases9 papers (2012–2020)Lawrence J. Appel · Johns Hopkins University Applied Physics Laboratory8 papers (2015–2020)Dahlia Garza · Henry Ford Hospital7 papers (2014–2018)David A. Bushinsky · University of Rochester Medical Center7 papers (2014–2018)Martha Mayo · University of Connecticut7 papers (2014–2018) · 7 papers (2014–2018)Mahboob Rahman · University School7 papers (2017–2023)Bertram Pitt · Bayer (Germany)6 papers (2014–2018) · 6 papers (2014–2016)Panduranga S. Rao · University of Illinois Chicago6 papers (2019–2025)Amanda H. Anderson · Tulane University6 papers (2014–2025)Edward Horwitz · University of Illinois Chicago5 papers (2017–2025)